Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionDFEOX - U.s. Core Equity 1 Portfolio - Institutional Class
Latest Disclosed Ownership139,794 shares
Latest Disclosed Value $ 3,932,405
DFEOX - U.s. Core Equity 1 Portfolio - Institutional Class ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On June 24, 2026 - DFEOX - U.s. Core Equity 1 Portfolio - Institutional Class filed a NPORT-P form disclosing ownership of 139,794 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $3,932,405 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 139,794 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $4,402,113 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-24 2026-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 139,794 0 0.00 3,932 15.78 0.0098
2026-03-27 2026-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 139,794 0 0.00 3,397 14.23 0.0088
2025-12-22 2025-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 139,794 0 0.00 2,973 -0.27 0.0078
2025-09-25 2025-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 139,794 -4,494 -3.11 2,982 -14.93 0.0082
2025-06-26 2025-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 144,288 -1,629 -1.12 3,505 6.47 0.0107
2025-03-26 2025-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 145,917 -30,141 -17.12 3,292 -14.25 0.0091
2024-12-23 2024-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 176,058 10,655 6.44 3,838 34.62 0.0109
2024-09-26 2024-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 165,403 56,629 52.06 2,852 74.16 0.0081
2024-06-25 2024-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 108,774 32,826 43.22 1,637 49.77 0.0050
2024-03-28 2024-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 75,948 0 0.00 1,094 16.03 0.0034
2023-12-20 2023-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 75,948 13,500 21.62 943 9.15 0.0033
2023-09-29 2023-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 62,448 11,612 22.84 864 6.67 0.0028
2023-06-23 2023-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 50,836 0 0.00 809 2.80 0.0028
2023-03-27 2023-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 50,836 0 0.00 787 11.63 0.0027
2022-12-28 2022-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 50,836 0 0.00 705 35.58 0.0025
2022-09-28 2022-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 50,836 32,640 179.38 521 276.81 0.0018
2022-06-28 2022-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 18,196 18,196 139 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.